• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3 炎性小体激活机制及其抑制剂的最新进展。

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.

机构信息

College of Animal Science and Technology, Key Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, Zhejiang Provincial Engineering Laboratory for Animal Health Inspection and Internet Technology, Zhejiang A&F University, Lin'an, 311300, Zhejiang, PR China.

Department of Veterinary Medicine, College of Animal Sciences, Zhejiang University, Hangzhou, 310058, Zhejiang, PR China.

出版信息

Cell Death Dis. 2019 Feb 12;10(2):128. doi: 10.1038/s41419-019-1413-8.

DOI:10.1038/s41419-019-1413-8
PMID:30755589
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6372664/
Abstract

The NLRP3 inflammasome is a multimeric protein complex that initiates an inflammatory form of cell death and triggers the release of proinflammatory cytokines IL-1β and IL-18. The NLRP3 inflammasome has been implicated in a wide range of diseases, including Alzheimer's disease, Prion diseases, type 2 diabetes, and some infectious diseases. It has been found that a variety of stimuli including danger-associated molecular patterns (DAMPs, such as silica and uric acid crystals) and pathogen-associated molecular patterns (PAMPs) can activate NLRP3 inflammasome, but the specific regulatory mechanisms of NLRP3 inflammasome activation remain unclear. Understanding the mechanisms of NLRP3 activation will enable the development of its specific inhibitors to treat NLRP3-related diseases. In this review, we summarize current understanding of the regulatory mechanisms of NLRP3 inflammasome activation as well as inhibitors that specifically and directly target NLRP3.

摘要

NLRP3 炎性小体是一种多聚体蛋白复合物,它启动细胞死亡的炎症形式,并引发促炎细胞因子 IL-1β 和 IL-18 的释放。NLRP3 炎性小体与多种疾病有关,包括阿尔茨海默病、朊病毒病、2 型糖尿病和一些传染病。已经发现,多种刺激物,包括危险相关分子模式(DAMPs,如二氧化硅和尿酸晶体)和病原体相关分子模式(PAMPs),可以激活 NLRP3 炎性小体,但 NLRP3 炎性小体激活的具体调节机制尚不清楚。了解 NLRP3 激活的机制将能够开发其特异性抑制剂来治疗 NLRP3 相关疾病。在这篇综述中,我们总结了 NLRP3 炎性小体激活的调节机制以及特异性和直接靶向 NLRP3 的抑制剂的最新认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/93b25143274e/41419_2019_1413_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/e9376809ca9b/41419_2019_1413_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/6b398f1534f2/41419_2019_1413_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/20f51fad833d/41419_2019_1413_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/93b25143274e/41419_2019_1413_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/e9376809ca9b/41419_2019_1413_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/6b398f1534f2/41419_2019_1413_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/20f51fad833d/41419_2019_1413_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd6e/6372664/93b25143274e/41419_2019_1413_Fig4_HTML.jpg

相似文献

1
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors.NLRP3 炎性小体激活机制及其抑制剂的最新进展。
Cell Death Dis. 2019 Feb 12;10(2):128. doi: 10.1038/s41419-019-1413-8.
2
The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.共价 NLRP3 炎性小体抑制剂冬凌草甲素可减轻小鼠心肌梗死后心肌纤维化和心脏重构。
Int Immunopharmacol. 2021 Jan;90:107133. doi: 10.1016/j.intimp.2020.107133. Epub 2020 Nov 7.
3
Secretion of IL-1β From Monocytes in Gout Is Redox Independent.痛风患者单核细胞中白细胞介素-1β的分泌与氧化还原无关。
Front Immunol. 2019 Jan 29;10:70. doi: 10.3389/fimmu.2019.00070. eCollection 2019.
4
α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β-stimulated murine astrocytes.α1-抗胰蛋白酶可减轻淀粉样 β 刺激的小鼠星形胶质细胞中 NLRP3 炎性小体的激活。
J Neuroinflammation. 2018 Sep 27;15(1):282. doi: 10.1186/s12974-018-1319-x.
5
NLRP3 inflammasome inhibition attenuates cisplatin-induced renal fibrosis by decreasing oxidative stress and inflammation.NLRP3 炎性小体抑制通过减少氧化应激和炎症来减轻顺铂诱导的肾纤维化。
Exp Cell Res. 2019 Oct 1;383(1):111488. doi: 10.1016/j.yexcr.2019.07.001. Epub 2019 Jul 2.
6
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation.NLRP3炎性小体抑制剂CP-456,773(CRID3)在皮肤和肺部炎症小鼠模型中的疗效与药理学研究
J Immunol. 2016 Sep 15;197(6):2421-33. doi: 10.4049/jimmunol.1600035. Epub 2016 Aug 12.
7
Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms.抑制 NLRP3 炎性小体可预防 LPS 诱导的小鼠炎症性痛觉过敏:NF-κB、Caspase-1/11、ASC、NOX 和 NOS 同工型的作用。
Inflammation. 2017 Apr;40(2):366-386. doi: 10.1007/s10753-016-0483-3.
8
Activation of the NLRP3 Inflammasome Is Associated with Valosin-Containing Protein Myopathy.NLRP3炎性小体的激活与含缬酪肽蛋白肌病相关。
Inflammation. 2017 Feb;40(1):21-41. doi: 10.1007/s10753-016-0449-5.
9
MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition.MCC950/CRID3 能够强烈靶向野生型 NLRP3 的 NACHT 结构域,但不能靶向与疾病相关的突变体,从而抑制炎症小体。
PLoS Biol. 2019 Sep 16;17(9):e3000354. doi: 10.1371/journal.pbio.3000354. eCollection 2019 Sep.
10
MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition.MCC950 直接针对 NLRP3 的 ATP 水解结构域,抑制炎症小体。
Nat Chem Biol. 2019 Jun;15(6):556-559. doi: 10.1038/s41589-019-0277-7. Epub 2019 May 13.

引用本文的文献

1
Lithocholic acid ameliorates ulcerative colitis via the PXR/TLR4/NF-κB/NLRP3 signaling pathway and gut microbiota modulation.石胆酸通过PXR/TLR4/NF-κB/NLRP3信号通路和肠道微生物群调节改善溃疡性结肠炎。
Cell Mol Life Sci. 2025 Sep 4;82(1):336. doi: 10.1007/s00018-025-05834-2.
2
Dynamic mechanisms and targeted interventions in cerebral ischemia-reperfusion injury: pathological cascade from ischemia to reperfusion and promising therapeutic strategies.脑缺血再灌注损伤的动态机制及靶向干预:从缺血到再灌注的病理级联反应及有前景的治疗策略
Front Neurosci. 2025 Aug 18;19:1649533. doi: 10.3389/fnins.2025.1649533. eCollection 2025.
3

本文引用的文献

1
PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation.分散的高尔基网络上的 PtdIns4P 介导 NLRP3 炎性小体的激活。
Nature. 2018 Dec;564(7734):71-76. doi: 10.1038/s41586-018-0761-3. Epub 2018 Nov 28.
2
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.炎症小体抑制可预防小鼠 α-突触核蛋白病和多巴胺能神经退行性变。
Sci Transl Med. 2018 Oct 31;10(465). doi: 10.1126/scitranslmed.aah4066.
3
Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming.
Chicken NLRP3 monoclonal antibody development and its antigenic epitope identification.
鸡NLRP3单克隆抗体的研制及其抗原表位鉴定
Poult Sci. 2025 Aug 6;104(11):105641. doi: 10.1016/j.psj.2025.105641.
4
MCC950 Alleviates Fat Embolism-Induced Acute Respiratory Distress Syndrome Through Dual Modulation of NLRP3 Inflammasome and ERK Pathways.MCC950通过对NLRP3炎性小体和ERK通路的双重调节减轻脂肪栓塞诱导的急性呼吸窘迫综合征。
Int J Mol Sci. 2025 Aug 5;26(15):7571. doi: 10.3390/ijms26157571.
5
Mitochondrial echoes in the bloodstream: decoding ccf-mtDNA for the early detection and prognosis of hepatocellular carcinoma.血液中的线粒体回声:解码循环游离线粒体DNA用于肝细胞癌的早期检测和预后评估
Cell Biosci. 2025 Aug 12;15(1):118. doi: 10.1186/s13578-025-01456-0.
6
Neutrophil extracellular traps and interleukin-1β in cystic fibrosis lung disease.中性粒细胞胞外诱捕网与白细胞介素-1β在囊性纤维化肺病中的作用
Front Immunol. 2025 Jul 28;16:1595994. doi: 10.3389/fimmu.2025.1595994. eCollection 2025.
7
A novel multi-target compound mitigates amyloid plaques, synaptic deficits, and neuroinflammation in Alzheimer's disease models.一种新型多靶点化合物可减轻阿尔茨海默病模型中的淀粉样斑块、突触缺陷和神经炎症。
Arch Pharm Res. 2025 Aug 6. doi: 10.1007/s12272-025-01562-0.
8
Aggregation potency and proinflammatory effects of SARS-CoV-2 proteins.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白的聚集能力和促炎作用。
Sci Rep. 2025 Aug 4;15(1):28446. doi: 10.1038/s41598-025-10013-1.
9
Optimizing PDIA1 Inhibition as a Strategy to Inhibit NLRP3 Inflammasome Activation and Activity.优化PDIA1抑制作为抑制NLRP3炎性小体激活和活性的策略。
ACS Chem Biol. 2025 Aug 15;20(8):1892-1901. doi: 10.1021/acschembio.5c00221. Epub 2025 Jul 29.
10
P2X7 receptor as a key player in pathological pain: insights into Neuropathic, inflammatory, and cancer pain.P2X7受体作为病理性疼痛的关键因素:对神经性疼痛、炎症性疼痛和癌痛的见解
Front Pharmacol. 2025 Jul 11;16:1585545. doi: 10.3389/fphar.2025.1585545. eCollection 2025.
氯离子调节动态 NLRP3 依赖性 ASC 寡聚化和炎症小体的引发。
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9371-E9380. doi: 10.1073/pnas.1812744115. Epub 2018 Sep 19.
4
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis.NLRP3 炎性体抑制剂 OLT1177 抑制急性关节炎小鼠模型中的关节炎症。
Arthritis Res Ther. 2018 Aug 3;20(1):169. doi: 10.1186/s13075-018-1664-2.
5
mtDNA synthesis ignites the inflammasome.线粒体DNA合成激活炎性小体。
Nat Rev Immunol. 2018 Sep;18(9):539. doi: 10.1038/s41577-018-0049-8.
6
New mitochondrial DNA synthesis enables NLRP3 inflammasome activation.新的线粒体 DNA 合成使 NLRP3 炎症小体激活。
Nature. 2018 Aug;560(7717):198-203. doi: 10.1038/s41586-018-0372-z. Epub 2018 Jul 25.
7
Targeting the NLRP3 inflammasome in inflammatory diseases.针对炎症性疾病中的NLRP3炎性小体
Nat Rev Drug Discov. 2018 Aug;17(8):588-606. doi: 10.1038/nrd.2018.97. Epub 2018 Jul 20.
8
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.冬凌草甲素是一种具有强抗炎症小体活性的 NLRP3 共价抑制剂。
Nat Commun. 2018 Jun 29;9(1):2550. doi: 10.1038/s41467-018-04947-6.
9
Cryo-EM structure of the gasdermin A3 membrane pore.气胀素 A3 膜孔的冷冻电镜结构。
Nature. 2018 May;557(7703):62-67. doi: 10.1038/s41586-018-0058-6. Epub 2018 Apr 25.
10
The E3 ubiquitin ligase Pellino2 mediates priming of the NLRP3 inflammasome.E3 泛素连接酶 Pellino2 介导 NLRP3 炎症小体的激活。
Nat Commun. 2018 Apr 19;9(1):1560. doi: 10.1038/s41467-018-03669-z.